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BACKGROUND: Human growth is susceptible to damage from insults,
particularly during periods of rapid growth. Identifying those periods and
the normative limits that are compatible with adequate growth and
development are the first key steps toward preventing impaired growth.
OBJECTIVE: This study aimed to construct international fetal growth
velocity increment and conditional velocity standards from 14 to 40 weeks’
gestation based on the same cohort that contributed to the INTER-
GROWTH-21st Fetal Growth Standards.
STUDY DESIGN: This study was a prospective, longitudinal study
of 4321 low-risk pregnancies from 8 geographically diverse pop-
ulations in the INTERGROWTH-21st Project with rigorous standardi-
zation of all study procedures, equipment, and measurements that
were performed by trained ultrasonographers. Gestational age was
accurately determined clinically and confirmed by ultrasound mea-
surement of crown-rump length at <14 weeks’ gestation. There-
after, the ultrasonographers, who were masked to the values,
measured the fetal head circumference, biparietal diameter, occi-
pitofrontal diameter, abdominal circumference, and femur length in
triplicate every 5 weeks (within 1 week either side) using identical
ultrasound equipment at each site (4e7 scans per pregnancy).
Velocity increments across a range of intervals between measures
were modeled using fractional polynomial regression.
RESULTS: Peak velocity was observed at a similar gestational age:
16 and 17 weeks’ gestation for head circumference (12.2 mm/wk),
and 16 weeks’ gestation for abdominal circumference (11.8 mm/wk)
and femur length (3.2 mm/wk). However, velocity growth slowed
down rapidly for head circumference, biparietal diameter, occipito-
frontal diameter, and femur length, with an almost linear reduction
toward term that was more marked for femur length. Conversely,
abdominal circumference velocity remained relatively steady
throughout pregnancy. The change in velocity with gestational age
was more evident for head circumference, biparietal diameter,
occipitofrontal diameter, and femur length than for abdominal
circumference when the change was expressed as a percentage of
fetal size at 40 weeks’ gestation. We have also shown how to obtain
accurate conditional fetal velocity based on our previous methodo-
logical work.
CONCLUSION: The fetal skeleton and abdomen have different velocity
growth patterns during intrauterine life. Accordingly, we have produced
international Fetal Growth Velocity Increment Standards to complement
the INTERGROWTH-21st Fetal Growth Standards so as to monitor fetal
well-being comprehensively worldwide. Fetal growth velocity curves may
be valuable if one wants to study the pathophysiology of fetal growth. We
provide an application that can be used easily in clinical practice to
evaluate changes in fetal size as conditional velocity for a more refined
assessment of fetal growth than is possible at present (https://lxiao5.
shinyapps.io/fetal_growth/). The application is freely available with the
other INTERGROWTH-21st tools at https://intergrowth21.tghn.org/
standards-tools/.
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Introduction
Fetal anthropometric measurements,
assessed by ultrasound scanning during
pregnancy, are taken as an indirect
means of assessing fetal size. Values are
plotted on one of the many reference
charts available, which have been devel-
oped using a variety of methods and
varying scientific rigor.1,2 Size measures
at the extreme ends (eg, below the 3rd,
5th, or 10th centiles, or above the 90th,
95th, or 97th centiles) of an often locally
derived reference distribution are typi-
cally interpreted as markers of growth
impairment for the purpose of identi-
fying fetuses at an increased risk of
adverse perinatal outcomes.
However, size and growth are not
synonymous terms—a fact that is
frequently ignored or misunderstood.3e6
Size is an individual measure taken at a
specific point in time; repeated size
measures represent distant variations in
size. In contrast, growth is a change in a
measure per unit of time—hence, a dy-
namic process.3,7 Specific charts for each
objective should be purposely derived
from several anthropometric measures
obtained longitudinally from the same
fetuses and expressed as distance or ve-
locity measures.5,8e10 Charts should
conform to the recommendations of the
World Health Organization (WHO) for
monitoring human growth and be based
on the prescriptive approach, that is, they
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should be international standards,
derived from healthy populations that
haveminimal nutritional, environmental,
or socioeconomic constraints on
growth.11
To our knowledge, the only published
international fetal growth charts that
conform completely to the WHO pre-
scriptive recommendations are those
constructed using data from the
INTERGROWTH-21st Fetal Growth
Longitudinal Study (FGLS).12e14 How-
ever, the use of such distance growth
charts in clinical practice may not be
sufficient to identify fetuses at a risk of
adverse outcomes because (1) actual
rates of skeletal and organ growth differ
across time, and (2) insults at different
time points during pregnancy almost
certainly have differential effects on the
growth and development of the skeleton
and individual organs.15 It should, there-
fore, be self-evident that the concept of the
differential growth velocity of fetal struc-
tures is in conflict with the practice of
using single summary indicators of fetal
growth, such as estimated fetal weight
(EFW). To illustrate the point, poor
placental nutrient transfer in the second
trimester of pregnancy leads to early-
onset fetal growth restriction (FGR)
including impaired skeletal growth,16
whereas in later pregnancy, it leads to
the depletion of fetal fat stores.17
Thus, to complement the existing in-
ternational INTERGROWTH-21st Fetal
Growth (Distance) Standards,12 we pre-
sent here international Fetal Growth (Ve-
locity Increment and Conditional Velocity)
Standards, based on the same serial ul-
trasound measures obtained from the
FGLS cohort. We also provide an easy-to-
use application (app) that enables assess-
ment of velocity increment and condi-
tional velocity for fetal head
circumference (HC), biparietal diameter
(BPD), occipitofrontal diameter (OFD),
abdominal circumference (AC), and fe-
mur length (FL) (https://lxiao5.shinyapps.
io/fetal_growth/). The app is freely avail-
able with the other INTERGROWTH-21st
tools at https://intergrowth21.tghn.org/
standards-tools/.
Materials and Methods
Design
INTERGROWTH-21st was a multi-
center, population-based project car-
ried out between 2009 and 2016 in 8
delimited urban areas: Pelotas, Brazil;
Turin, Italy; Muscat, Oman; Oxford,
United Kingdom; Seattle, WA; Shunyi
County, a suburban district of the
Beijing municipality, China; the central
area of the city of Nagpur (Central
Nagpur), Maharashtra, India; and the
Parklands suburb of Nairobi, Kenya.12
At each study site, we recruited
women with no clinically relevant
obstetrical, gynecologic, or medical
history, who initiated antenatal care
<14þ0 weeks’ gestation by menstrual
dates and met the entry criteria of
optimal health, nutrition, education,
and socioeconomic status. This resulted
in a group of educated, affluent, clini-
cally healthy women, with adequate
nutritional status, who by definition
were at a low risk of FGR and preterm
birth. A detailed description of the
entry criteria and definitions has been
published previously.12
The last menstrual period (LMP)
was used to calculate gestational age
provided that (1) the date was certain,
(2) the woman had a regular 24- to
32-day menstrual cycle, (3) she had
not been using hormonal contracep-
tion or breastfeeding in the preceding
2 months, and (4) any discrepancy
between the gestational ages based on
LMP and crown-rump length (CRL),
measured by ultrasound at 9þ0 to 13þ6
weeks from LMP was 7 days, using
the formula described by Robinson
and Fleming.18 To ensure that CRL
measures were interpreted consis-
tently, the Robinson and Fleming for-
mula was loaded into all study
ultrasound machines; whenever
another machine had to be used
locally for CRL measurement, a con-
version table extracted from the same
formula was provided. The CRL tech-
nique was also standardized across
sites, and all ultrasonographers were
uniformly trained.19
FGLS was 1 of the 9 component
studies of the INTERGROWTH-21st
Project, which has been described in
detail elsewhere.12e14,20 In brief, FGLS
involved performing serial examina-
tions with the same ultrasound ma-
chine (Philips HD-9, Philips
Ultrasound, USA with curvilinear
abdominal transducers C5-2, C6-3,
V7-3) every 5 weeks (within 1 week
either side) after an initial scan at <14
weeks’ gestation that confirmed the
certain clinical dates; hence, the
possible ranges of scan visits were at
14 to 18, 19 to 23, 24 to 28, 29 to 33,
34 to 38, and 39 to 42 weeks’ gesta-
tion. At each visit after 14 weeks’
AJOG at a Glance
Why was this study conducted?
This study aimed to identify fetuses at risk of adverse outcomes because actual
rates of skeletal and organ growth differ across time, and insults at different time
points during pregnancy almost certainly have differential effects on growth.
Key findings
We present fetal velocity standards using fetal data collected prospectively in a
rigorous scientific manner from low-risk women, whose newborns have been
followed until 2 years of age. We provide an application that can be used easily in
clinical practice to evaluate changes in fetal size as conditional velocity for a more
refined assessment of fetal growth than is possible at present.
What does this add to what is known?
These standards may be valuable if one wants to study the pathophysiology of
fetal growth comprehensively. They perfectly complement our existing fetal
growth standards (distance), which are already being used clinically in many
settings.
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gestation, the fetal measures obtained
were HC, BPD, OFD, AC, and FL.
Each parameter was measured in
triplicate from 3 separately obtained
images of each structure. These studies
have provided robust evidence of the
similarities in skeletal growth from
early pregnancy to 2 years of age in
the infants of healthy women, irre-
spective of ancestry, and have now
been extended beyond skeletal growth
to neurodevelopment.14,20
The measurement protocol,
including masking the ultrasonogra-
pher to the values, and the unique
training, standardization, and quality
control procedures have been reported
elsewhere.21e24 In brief, ultrasonogra-
phers were recruited based on their
technical experience, motivation, reli-
ability, and ability to speak the local
languages. They underwent rigorous
training consisting of acquiring theo-
retical knowledge and familiarity with
the study protocol, ultrasound machine
and operations manual, and data
collection and quality control measures.
Centralized hands-on training and
initial standardization were also con-
ducted.12 In addition, site-specific
standardization was conducted at reg-
ular intervals by the Ultrasound Quality
Control Unit, based in Oxford, to
ensure proper use of the ultrasound
equipment, calibration, and adherence
to the protocol. A quality control system
was implemented throughout the study
based on (1) assessing the distributions
of the 3 masked measurements taken
for HC, BPD, OFD, AC, and FL at each
scan; and (2) the Ultrasound Quality
Control Unit taking a random 10%
sample of all ultrasound images,
assessing their quality using a validated
scoring system, and remeasuring
them.24 Only after 3 measurements of
each structure were recorded was each
average value revealed to the ultraso-
nographer for clinical purposes. The
reproducibility of the fetal ultrasound
measurements has been previously
reported.23
The cohort enrolled in FGLS was fol-
lowed up to 2 years of age and evaluated
for their skeletal growth, nutrition,
health, and the WHO gross motor
milestones.20,25
The INTERGROWTH-21st Project
was approved by the Oxfordshire
Research Ethics Committee C (refer-
ence: 08/H0606/139), the research ethics
committees of the individual partici-
pating institutions, and the correspond-
ing regional health authorities where the
project was implemented. Participants
provided written consent to be involved
in the study. All documentation, pro-
tocols, data collection forms, and clinical
tools are freely available on the
INTERGROWTH-21st website (https://
intergrowth21.tghn.org/).
Statistical methodology
The decision to pool the data from all the
study sites to construct fetal velocity
increment standards was based on our
detailed, previously published analyses
of the same data,14 using the strategy
recommended in the WHO Multicenter
Growth Reference Study,26 that pro-
duced the WHO Child Growth Stan-
dards.27 Our overall aim was to produce
velocity increments that change
smoothly with gestational age and
maximize simplicity without compro-
mising model fit; we have, in addition,
produced fetal conditional velocity
standards. The general strategy and sta-
tistical considerations for the analysis of
the FGLS data are described in detail
elsewhere.28,29
Velocity increment
Velocity increment was calculated as the
difference between 2 ultrasound mea-
sures denoted by Y1 and Y2, divided by
the time interval between them, that is,
FIGURE 1
Increments in fetal HC, AC, and FL (mm/wk) according to gestational age
(weeks) for all of the sites combined
The fitted 3rd, 50th, and 97th centiles are superimposed.
AC, abdominal circumference; FL, femur length; HC, head circumference.
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t1, and t2, respectively.
30e33 The velocity
increment rate of growth per week is as
follows:
Velocity increment ¼
ðY2  Y1Þ = ðt2  t1Þ mm =wk
Equation 1
Velocity increments per week were
modeled as a function of gestational age
at the midetime point between any pair
of observations on a continuous scale
using fractional polynomial regression.34
To account for increasing variability with
gestational age, the mean and standard
deviation (SD) were modeled separately
using fractional polynomial regression34
of the best fitting powers for HC, BPD,
OFD, AC, and FL. To determine velocity
increments, we analyzed pairs of obser-
vations taken during the course of the
serial ultrasound examinations per-
formed every 5 weeks (within 1 week
either side).
Goodness of fit incorporated visual
inspection of overall model fit by
comparing empirical centiles (calculated
per complete week of gestation, eg, 38
weeks¼38þ0 to 38þ6) to the fitted cen-
tiles, using quantile-quantile (q-q) plot
of the residuals, plots of residuals vs
fitted values, and the distribution of
fitted Z-scores across gestational ages.
The fitted models were used to obtain
velocity centiles on the relative change
over each gestational week. Velocity in-
crements were computed as the average
relative change for the average week-
specific measurement. These velocities
were determined across gestational ages
from 16 to 40 weeks and for each fetal
biometry.
Conditional velocity
In the context of this paper, we
considered conditional velocity as the
rate of growth (often referred to as
growth velocity) that evaluates velocity
based on the change in relative
attained size between 2 time
points.33,35 A velocity Z-score of 0 de-
notes perfect tracking, whereas a score
above or below 0 represents faster or
slower growth than expected between
the specified times. However, an
important consideration is the well-
known phenomenon of regression to
the mean,36 as many, but not all, small
fetuses will on average catch up and
many, but not all, large fetuses will
“catch down.”37 Regression to the
mean has far-reaching implica-
tions36,38,39 not often accounted for,
especially when assessing velocity. The
correlation coefficient is a direct
measure of regression to the
mean.37,38,40 The conditional SD
scores (cSDSs) account for regression
to the mean by adjusting for the cor-
relation between the 2 time points.37
The statistical methodology that
separately modeled the same data and
produced estimates of the correlation
between any pair of fetal HC, BPD,
OFD, AC, or FL measures between 14
and 40 weeks’ gestation has recently
been published.41 In brief, to account
for nonnormality of fetal measure-
ments, we applied a 2-stage approach.
The first stage involved finding a
suitable transformation of the raw
fetal measurements, as the marginal
distributions of ultrasound measure-
ments were nonnormal using Cole’s
Lambda (l), Mu (m) and Sigma (s)
(LMS) transformation42 of 3
TABLE 1
Smoothed centiles for FHC velocity increment (mm/wk) according to
gestational age
Gestational age (wk)
FHC
C3 C5 C10 C50 C90 C95 C97
16 10.62 10.82 11.14 12.24 13.34 13.65 13.85
17 10.52 10.73 11.06 12.22 13.37 13.70 13.91
18 10.39 10.62 10.96 12.17 13.38 13.72 13.94
19 10.23 10.47 10.83 12.09 13.35 13.71 13.94
20 10.04 10.28 10.66 11.97 13.29 13.67 13.91
21 9.81 10.06 10.45 11.82 13.20 13.59 13.84
22 9.54 9.80 10.21 11.64 13.06 13.47 13.73
23 9.24 9.51 9.93 11.41 12.89 13.32 13.59
24 8.89 9.18 9.61 11.15 12.68 13.12 13.40
25 8.51 8.80 9.26 10.85 12.43 12.89 13.18
26 8.08 8.39 8.86 10.50 12.14 12.61 12.91
27 7.62 7.93 8.41 10.11 11.81 12.29 12.61
28 7.10 7.43 7.93 9.68 11.43 11.93 12.25
29 6.55 6.88 7.39 9.20 11.01 11.52 11.86
30 5.94 6.29 6.82 8.68 10.54 11.07 11.41
31 5.29 5.65 6.19 8.11 10.02 10.57 10.92
32 4.60 4.96 5.52 7.49 9.46 10.02 10.39
33 3.85 4.22 4.80 6.82 8.85 9.43 9.80
34 3.05 3.44 4.03 6.11 8.19 8.78 9.16
35 2.21 2.60 3.21 5.34 7.48 8.08 8.48
36 1.31 1.71 2.34 4.52 6.71 7.34 7.74
37 0.36 0.77 1.41 3.65 5.90 6.54 6.95
38 -0.64 -0.22 0.44 2.73 5.03 5.68 6.11
C, centile; FHC, fetal head circumference.
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parameters (location, scale, and
skewness using Box-Cox Cole-Green
distribution42) and 4 parameters
(location, scale, skewness, and kurtosis
using Box-Cox t-distribution43 and
Box-Cox power exponential distribu-
tion44) to standardized deviations (Z-
scores). In the second stage, a corre-
lation model for a Gaussian process
was fitted, yielding a correlation for
any pair of observations made between
14 and 40 weeks of gestation. To
model correlations, parametric and
nonparametric models were used.
Four exponential parametric models
were applied, and because growth
measurements might have non-
ignorable measurement errors, a
nugget effect term for the exponential
model was also explored along with 2
nonparametric models for modeling
correlation. Further details are pre-
sented in a previous report.41 We used
the correlation coefficients from this
work to calculate the fetal conditional
velocity for HC, BPD, OFD, AC, and
FL using the cSDS approach.37
The FGLS data were converted to Z-
scores using the published international
INTERGROWTH-21st Fetal Growth
(Distance) Standards derived from the
same data.12 Let fetal biometry Z-scores
be denoted by Z1 and Z2 at time points t1
and t2, respectively, and r12 the correla-
tion coefficient between Z1 and Z2. The
cSDS between the 2 time points is given
by:38
cSDS ¼ ðZ2 r12Z1Þ
 ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ð1 r212Þ
q
;
Equation 2
where t1<t2.
37
All analyses were performed in STATA
software, version 11.2 (StataCorp LP,
College Station, TX) and R statistical
software (R Foundation for Statistical
Computing).
Results
Overall results
In the original FGLS, a total of 4321
women had live singleton births in the
absence of severe maternal conditions or
congenital abnormalities detected by
ultrasound or at birth; this forms the
included study sample. The median
number of ultrasound scans (excluding
the dating scan) was 5.0 (mean, 4.9; SD,
0.8; range, 4e7), and 97% of women had
4 scans (mean, 5.0; SD, 0.6; range,
4e7), indicating that the participants
adhered well to the protocol. The same
population was used for this analysis.
The high protocol adherence meant
that the intervals between adjacent
measurements were mostly 4 weeks
(n¼3836), 5 weeks (n¼8871), or 6 weeks
(n¼2411), or intervals involving a
combination or multiples of the 4-, 5-,
and 6-week intervals: 8 weeks (n¼721),
9 weeks (n¼2817), 10 weeks (n¼5186),
11 weeks (n¼1932), and 12 weeks
(n¼356). In total, 20,030 fetal measures
were used to construct the Fetal Growth
Velocity Standards.
A scatterplot of increments in rawHC,
AC, BPD, OFD, and FL data (mm/wk)
and the fitted 3rd, 50th, and 97th
smoothed centiles according to gesta-
tional age (weeks) is shown in Figure 1
and Supplemental Figure 1.
The baseline characteristics of the
study cohort across the 8 urban areas
previously have been shown to be very
TABLE 2
Smoothed centiles for fetal BPD velocity increment (mm/wk) according to
gestational age
Gestational age (wk)
BPD
C3 C5 C10 C50 C90 C95 C97
16 2.4 2.5 2.6 3.2 3.7 3.9 4.0
17 2.4 2.5 2.7 3.2 3.8 3.9 4.0
18 2.4 2.5 2.7 3.2 3.8 3.9 4.0
19 2.4 2.5 2.7 3.2 3.8 4.0 4.1
20 2.4 2.5 2.7 3.2 3.8 4.0 4.1
21 2.4 2.5 2.7 3.2 3.8 3.9 4.1
22 2.4 2.5 2.7 3.2 3.8 3.9 4.0
23 2.3 2.5 2.6 3.2 3.7 3.9 4.0
24 2.3 2.4 2.6 3.1 3.7 3.9 4.0
25 2.2 2.3 2.5 3.1 3.6 3.8 3.9
26 2.2 2.3 2.4 3.0 3.6 3.7 3.8
27 2.1 2.2 2.3 2.9 3.5 3.6 3.8
28 2.0 2.1 2.2 2.8 3.4 3.5 3.7
29 1.8 1.9 2.1 2.7 3.3 3.4 3.5
30 1.7 1.8 2.0 2.6 3.1 3.3 3.4
31 1.6 1.7 1.8 2.4 3.0 3.2 3.3
32 1.4 1.5 1.7 2.3 2.8 3.0 3.1
33 1.2 1.3 1.5 2.1 2.7 2.8 3.0
34 1.0 1.1 1.3 1.9 2.5 2.7 2.8
35 0.8 0.9 1.1 1.7 2.3 2.4 2.6
36 0.6 0.7 0.9 1.5 2.1 2.2 2.3
37 0.3 0.4 0.6 1.2 1.8 2.0 2.1
38 0.1 0.2 0.4 1.0 1.6 1.7 1.8
BPD, biparietal diameter; C, centile.
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similar, which was expected because
women were selected using the same
clinical and demographic criteria
(Supplemental Table). The pregnancy
and perinatal events for the complete
cohort, which confirmed their status
as healthy women at low risk of
impaired fetal growth, have also been
published before.12 In addition, the
infant cohort remained healthy
with adequate growth, motor devel-
opment, and associated behaviors up
to 2 years of age,20,45 supporting its
appropriateness for the construction
of the INTERGROWTH-21st Fetal
Growth (Distance) Standards12 and
associated Preterm Postnatal Growth
Standards.46
Velocity increments
The rate of growth for HC was the
highest at 16 and 17 weeks’ gestation
(12.2 mm/wk), and the velocity slowed
down with an almost linear reduction
(9.7mm/wk at 28 weeks vs 6.1mm/wk at
34 weeks’ gestation) toward term
(Figure 1; Table 1). For BPD, peak ve-
locity was observed at 19 and 20 weeks’
gestation (3.2 mm/wk) (Supplemental
Figure 1, Table 2). OFD had an earlier
observed peak velocity at 16 weeks’
gestation (4.5 mm/wk) (Supplemental
Figure 1; Table 3). A similar pattern of
growth was seen with the other skeletal
measure (FL). The rate of FL growth was
the highest very early in pregnancy at 16
weeks’ gestation (mean, 3.2 mm/wk),
which reduced to 2.2mm/wk at 28 weeks
and 1.8 mm/wk at 34 weeks’ gestation
(Figure 1; Table 4). FL velocity decreased
linearly with increasing gestational age.
Conversely, the velocity growth for AC
(consisting of abdominal organs and
subcutaneous fat) was relatively steady
across most gestational ages, from 16
weeks (mean, 11.8 mm/wk) to 10.4 mm/
wk at 28 weeks and 9.7 mm/wk at 34
weeks’ gestation. This pattern is clearly
different from that of HC (Figure 1;
Table 5).
Figure 2 shows the velocity increment
growth presentations of fetal HC, AC,
and FL relative to the expected attained
size at 40 weeks’ gestation according to
the published international
INTERGROWTH-21st Fetal Growth
(Distance) Standards.12 It is clear that
90% (30.2 cm at 33 weeks and 33.4 cm at
40 weeks) of the HC size at term was
reached by 33 weeks’ gestation
(Figure 2).
The change in velocity with gesta-
tional age was more clearly seen in the
skeletal markers for HC, BPD, OFD, and
FL than AC when expressed as a per-
centage of size at 40 weeks’ gestation12
(Figure 2; Supplemental Figure 2). AC
gain was steady at around 3% per week
(range, 2.7%e3.4%) of the total size at
term; HC gain was close to 4% of the
term size per week at 16 weeks and<1%
after 36 weeks’ gestation (range, 0.8%
e3.7%). FL gain was highest in early
pregnancy and decreased linearly with
advancing gestational age (range, 2%
e4.5%).
Tables 1, 2, 3, 4, and 5 present the
predicted 3rd, 5th, 10th, 50th, 90th,
95th, and 97th centiles for velocity in-
crements between 14 and 40 weeks’
gestation for HC, BPD, OFD, AC, and
FL, respectively, to match the previously
published Fetal Growth (Distance)
Standards.12 The corresponding equa-
tions for the mean and SD from the
fractional polynomial regression models
for each measure are presented in
Table 6, allowing for calculations by
TABLE 3
Smoothed centiles for fetal OFD velocity increment (mm/wk) according to
gestational age
Gestational age (wk)
OFD
C3 C5 C10 C50 C90 C95 C97
16 3.9 4.0 4.1 4.5 4.9 5.0 5.1
17 3.8 3.9 4.0 4.5 4.9 5.0 5.1
18 3.7 3.8 3.9 4.4 4.9 5.0 5.1
19 3.6 3.7 3.9 4.4 4.9 5.0 5.1
20 3.5 3.6 3.8 4.3 4.9 5.0 5.1
21 3.4 3.5 3.6 4.2 4.8 5.0 5.1
22 3.2 3.3 3.5 4.1 4.8 4.9 5.0
23 3.1 3.2 3.4 4.0 4.7 4.9 5.0
24 2.9 3.0 3.2 3.9 4.6 4.8 4.9
25 2.7 2.9 3.1 3.8 4.5 4.7 4.9
26 2.5 2.7 2.9 3.7 4.4 4.6 4.8
27 2.3 2.5 2.7 3.5 4.3 4.5 4.7
28 2.1 2.3 2.5 3.3 4.2 4.4 4.6
29 1.9 2.0 2.3 3.2 4.0 4.3 4.4
30 1.6 1.8 2.1 3.0 3.9 4.1 4.3
31 1.4 1.6 1.8 2.8 3.7 4.0 4.1
32 1.1 1.3 1.6 2.5 3.5 3.8 4.0
33 0.8 1.0 1.3 2.3 3.3 3.6 3.8
34 0.5 0.7 1.0 2.1 3.1 3.4 3.6
35 0.2 0.4 0.7 1.8 2.9 3.2 3.4
36 0.1 0.1 0.4 1.5 2.6 2.9 3.1
37 0.5 0.3 0.1 1.2 2.4 2.7 2.9
38 0.8 0.6 0.3 0.9 2.1 2.4 2.6
C, centile; OFD, occipitofrontal diameter.
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readers of any desired centiles or
Z-scores according to gestational age.
For example, centiles can be calculated
as meanZSD, where Z is 1.88,
1.645, 1.28, 0, 1.28, 1.645, and 1.88
for the 3rd, 5th, 10th, 50th, 90th, 95th,
and 97th centiles, respectively. Printable
charts and related tools will be available
free of any charge at http://www.
intergrowth.org.uk.
Conditional velocity
We randomly selected measures across
different gestational ages and used the
fitted correlations and observed Z-
scores12 to illustrate conditional
velocity (cSDS) for a single fetus ac-
cording to gestational age. For demon-
stration purposes, we show in Figure 3,
AeD, 4 hypothetical fetal HC growth
scenarios likely to be observed during
pregnancy: a fetus that exhibits the ex-
pected average rate of growth
throughout pregnancy (scenario A), a
fetus whose longitudinal pattern of
growth exhibits possible microcephaly
(scenario B), a fetus whose pattern of
growth is within 2 SD of an established
fetal HC standard (scenario C), and a
fetus whose longitudinal pattern of
growth exhibits possible macrosomia
(scenario D).
These calculations and visual illus-
trations are embedded in the R-shiny
app (https://lxiao5.shinyapps.io/shiny
calculator/). In addition, the app con-
verts fetal measures to Z-scores ac-
cording to the international Fetal
Growth (Distance) Standards of the
INTERGROWTH-21st Project12; en-
ables correlations to be calculated be-
tween any pair of fetal biometry
measures to calculate conditional ve-
locity (cSDS); and calculates velocity
increments for HC, BPD, OFD, AC,
and FL (https://lxiao5.shinyapps.io/
shinycalculator/).
Comment
Principal findings
We described growth velocity increment
and estimated velocity standards and
conditional velocity using highly stan-
dardized ultrasound measures of the
skeleton and abdominal organs or fat of
fetuses from the FGLS cohort of the
INTERGROWTH-21st Project. This is
the same cohort fromwhich not only the
INTERGROWTH-21st Fetal Growth
(Distance) Standards12 but also the in-
ternational standards for the following
were developed: (1) symphysis-fundal
height,47 (2) gestational weight gain,48
(3) early and late pregnancy dating,49
(4) EFW,50 (5) newborn body composi-
tion,51 and (6) postnatal growth of pre-
term infants.46 Hence, the new velocity
standards allow, for the first time, dis-
tance and velocity growth in utero to be
assessed using longitudinal growth tra-
jectories from the same international
populations of pregnant women at a low
risk for adverse health and nutritional
and environmental factors, that is, pre-
scriptive populations.
In addition, for the first time in the
obstetrical ultrasound literature, we fol-
lowed up the cohort until 2 years of age
and showed that the mean skeletal
growth of the infants participating in
FGLS was well within the WHO Child
Growth Standards (50th centile for HC,
49th centile for length, and 58th centile
for weight). These findings strongly
suggest that the fetal growth velocity
increments described here are likely to
be observed in healthy populations
worldwide.
TABLE 4
Smoothed centiles for fetal FL velocity increment (mm/wk) according to
gestational age
Gestational age (wk)
FL
C3 C5 C10 C50 C90 C95 C97
16 2.7 2.8 2.9 3.2 3.6 3.7 3.7
17 2.6 2.7 2.8 3.1 3.5 3.6 3.6
18 2.5 2.6 2.7 3.0 3.4 3.5 3.5
19 2.4 2.5 2.6 2.9 3.3 3.4 3.4
20 2.3 2.4 2.5 2.8 3.2 3.3 3.3
21 2.2 2.3 2.4 2.7 3.1 3.2 3.3
22 2.1 2.2 2.3 2.6 3.0 3.1 3.2
23 2.0 2.1 2.2 2.6 2.9 3.0 3.1
24 1.9 2.0 2.1 2.5 2.9 3.0 3.0
25 1.8 1.9 2.0 2.4 2.8 2.9 3.0
26 1.7 1.8 1.9 2.3 2.7 2.9 2.9
27 1.7 1.7 1.9 2.3 2.7 2.8 2.9
28 1.6 1.6 1.8 2.2 2.6 2.7 2.8
29 1.5 1.6 1.7 2.1 2.6 2.7 2.8
30 1.4 1.5 1.6 2.0 2.5 2.6 2.7
31 1.3 1.4 1.5 2.0 2.4 2.6 2.6
32 1.2 1.3 1.4 1.9 2.4 2.5 2.6
33 1.1 1.2 1.3 1.8 2.3 2.5 2.5
34 1.0 1.1 1.3 1.8 2.3 2.4 2.5
35 0.9 1.0 1.2 1.7 2.2 2.3 2.4
36 0.8 0.9 1.1 1.6 2.1 2.3 2.4
37 0.7 0.8 1.0 1.5 2.1 2.2 2.3
38 0.6 0.7 0.9 1.4 2.0 2.2 2.3
C, centile; FL, femur length.
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Results
Our results show that peak growth ve-
locity was observed between 16 and 17
weeks’ gestation for the fetal skeleton
(HC and FL) and abdomen (AC); how-
ever, the observed patterns were mark-
edly different. OFD had an earlier peak
velocity at 16 weeks than 19 and 20
weeks’ gestation for BPD, which implies
that the fetal head may have a rate of
growth that promotes a slightly dispro-
portionate shape to accommodate
certain brain structures.
Growth velocity slowed down rapidly
for HC and FL and at an almost linear
rate in the case of FL; by contrast, it
remained steady throughout pregnancy
for AC. In addition, there was a larger
variability in the AC velocity values than
those for HC and FL, especially in the
second half of pregnancy. Taken
together, the findings show that overall
skeletal growth is a biological process
that has the highest rate of growth in the
first part of pregnancy; linear skeletal
growth (FL) is even more pronounced.
How do our results compare with
previously published studies? For HC,
Deter et al,52 using the Rossavik growth
model in a cohort of 20 fetuses, re-
ported an earlier peak velocity at 14
weeks (14 mm/wk), which decreased to
9 mm/wk at 30 weeks and 5 mm/wk at
38 weeks’ gestation.53 Similarly, for AC,
peak velocity was earlier (12 mm/wk at
14 weeks and reduced to 11 mm/wk at
30 weeks of gestation). Todros et al,54
applying a growth model similar to
Rossavik’s found that the peak velocity
was at around 16 weeks’ gestation for
both HC and BPD. Similarly, Guihard-
Costa et al55 reported multiphasic pat-
terns of growth velocity, with a com-
mon peak velocity at about 16 weeks of
gestation and no sex differences in
growth velocity. Bertino et al56 reported
similar findings to ours: in 238 fetuses,
peak velocity was reached at 17.3 weeks’
gestation with a rapid increase in the
early part of the second trimester, which
then decreased up until the end of
pregnancy.
Several studies using different selec-
tion criteria, hospital populations, ul-
trasound equipment, and
methodologies have reported a decrease
in FL linear growth velocity by gesta-
tional age.57e59 However, it is important
to bear in mind that the populations
studied were not equivalent and that FL
is measured differently by modern
equipment; hence, the values are not
entirely comparable.60 This is an
important issue because hospitals are
still using FL charts based on equipment
that is no longer in use, which increases
the risk of misclassifying fetuses.
Recently, Grantz et al61 studied the
relationship between fetal growth ve-
locity and self-reported maternal
ethnicity. The findings were similar to
those of this study: FL velocity was be-
tween 3.4 and 3.5 mm/wk at 16 weeks
(3.2 mm/wk in our study), 2.2mm/wk at
28 weeks (2.2 mm/wk in our study), and
between 1.8 and 1.9 mm/wk at 34 weeks’
gestation (1.8 mm/wk in our study).
Therefore, as the INTERGROWTH-21st
Project has clearly demonstrated, fetal
linear skeletal growth velocity seems to
be very similar regardless of the mother’s
geographic location, country of origin,
or self-reported ethnicity, which adds
considerable support to the concept that
growth among healthy, low-risk fetuses
is universal.62
AC, which is an indicator of abdom-
inal organ growth (mostly liver and
TABLE 5
Smoothed centiles for AC velocity increment (mm/wk) according to
gestational age
Gestational age (wk)
AC
C3 C5 C10 C50 C90 C95 C97
16 9.4 9.7 10.1 11.8 13.4 13.9 14.2
17 9.1 9.5 9.9 11.6 13.3 13.8 14.1
18 8.9 9.2 9.7 11.5 13.2 13.7 14.0
19 8.7 9.1 9.6 11.3 13.1 13.6 13.9
20 8.5 8.9 9.4 11.2 13.0 13.5 13.9
21 8.3 8.7 9.2 11.1 12.9 13.5 13.8
22 8.1 8.5 9.0 11.0 12.9 13.5 13.8
23 7.9 8.3 8.9 10.9 12.9 13.4 13.8
24 7.7 8.1 8.7 10.8 12.8 13.4 13.8
25 7.5 7.9 8.5 10.7 12.8 13.4 13.8
26 7.3 7.7 8.3 10.6 12.8 13.5 13.9
27 7.0 7.5 8.1 10.5 12.8 13.5 13.9
28 6.8 7.2 7.9 10.4 12.8 13.5 14.0
29 6.5 7.0 7.7 10.3 12.8 13.6 14.0
30 6.3 6.8 7.5 10.2 12.8 13.6 14.1
31 6.0 6.5 7.3 10.1 12.9 13.7 14.2
32 5.7 6.2 7.0 10.0 12.9 13.7 14.3
33 5.4 5.9 6.8 9.9 12.9 13.8 14.4
34 5.0 5.6 6.5 9.7 13.0 13.9 14.5
35 4.7 5.3 6.3 9.6 13.0 14.0 14.6
36 4.3 5.0 6.0 9.5 13.0 14.1 14.7
37 3.9 4.6 5.7 9.4 13.1 14.2 14.8
38 3.5 4.2 5.3 9.2 13.2 14.3 15.0
AC, abdominal circumference; C, centile.
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subcutaneous fat), is strongly influenced
by the underlying nutritional status of
the population being studied. In devel-
oped countries and in countries
suffering from the double burden of
malnutrition, where a large proportion
of the population is in the midst of the
obesity epidemic, it is becoming
increasingly clear that overweight or
obesity is often initiated in utero.63
Hence, comparing AC growth in previ-
ous studies54,55 with the FGLS cohort of
healthy, low-risk women is a less relevant
question given that fetal AC values in
unselected populations are influenced by
the distribution of maternal faterelated
markers, that is, the fetal AC may be
larger in obese women than in those with
a normal body mass index.64
Grantz et al,61 in a US population,
reported AC velocity values early in
pregnancy that were very similar to our
study: 11.7 to 12.2 mm/wk at 16 weeks
(11.8 mm/wk in our study) and 10.3 to
10.9 mm/wk at 28 weeks’ gestation (10.4
mm/wk in our study). However, in the
third trimester, there was clear evidence
of AC overgrowth: 10.1 to 10.8 mm/wk
at 34 weeks’ gestation vs 9.7 mm/wk in
our study. In short, fat may be deposited
in the fetal abdomen faster in some
populations than in others, resulting in
overweight, despite similar skeletal
growth velocities.
Clinical implications
Our analysis of skeletal and abdominal
velocity increments, expressed as a
percentage of attained fetal size at 40
weeks’ gestation, also showed differential
growth velocity patterns. This finding
has important clinical consequences
because of how EFW is utilized in
obstetrical practice. Based on these
findings and taking into account basic
analytical principles, summary measures
such as EFW should not be used if there
is evidence of biological heterogeneity
among the parameters to be combined.
Thus, the observation that similar EFW
estimations can be obtained from
different permutations of HC, AC, and
FL values may explain the large errors
often seen in EFW values regardless of
which equation is used.65,66
The biological significance of the
heterogeneity in the velocity and timing
of fetal growth is best appreciated by
examining how an intrauterine insult,
such as infection with the Zika virus
(ZIKV), can have varying effects at
different stages of pregnancy. Infection
in the first trimester has clearly been
associated with massive disruption to
brain development and a decrease in the
rate of head growth, resulting in
microcephaly.67 However, brain dam-
age can also arise from infection late in
the pregnancy despite head size
remaining within the normal limits.68,69
Certainly, in our data set, 90% of HC at
term was reached by 33 weeks’ gesta-
tion, that is, HC values at birth and at 33
weeks’ gestation were very similar.
Therefore, a ZIKV infection after 33
weeks’ gestation may still lead to brain
damage but the effect on the skull size
will be limited, which means that diag-
nosing ZIKV infection based solely on
the presence of microcephaly at birth
will be associated with a false-negative
rate. We can extend this type of com-
parison into childhood. The mean HC
of the same cohort at 2 years of age was
47.8 cm; although we acknowledge
differences in measurement techniques,
on average, two-thirds of a 2-year-old
child’s HC is attained by 33 weeks’
gestation.
Strengths and limitations
This study’s findings could have
important implications for clinical
practice, as improved assessment of
FIGURE 2
Median fetal velocity increments for HC (green), AC (red), and FL (blue)
expressed as a percentage of attained fetal size at 40 weeks’ according to
INTERGROWTH-21st Fetal Standards12
Adapted from Papageorghiou et al.12
AC, abdominal circumference; FL, femur length; HC, head circumference; INTERGROWTH-21st, International Fetal and Newborn Growth
Consortium for the 21st Century.
Ohuma el al. Fetal growth velocity standards. Am J Obstet Gynecol 2020.
ajog.org OBSTETRICS Original Research
MONTH 2020 American Journal of Obstetrics& Gynecology 1.e9
fetal growth patterns could potentially
lead to more personalized antenatal
care. In other words, the use of the
standards described here could help
distinguish healthy from disturbed fetal
growth for both the management of
individual pregnancies and for
screening purposes. However, there are
practical challenges. A similar approach
has been advocated in the past for
monitoring child growth; however, it
has not been adopted in routine practice
largely because the calculations are
complex and the results are difficult to
interpret. To illustrate the point, the
choice of interval length between mea-
sures affects the results: the shorter the
interval, the higher the variability in
growth and measurement error than
the actual growth. Guihard-Costa et al55
recommend a 3-week interval as the
minimum time interval in which the
growth rate may be statistically signifi-
cant, taking into account the number of
cases, the minute fluctuations of growth
rate in short periods, and the individual
variability of growth velocity. However,
extending the time interval loses the
benefit of assessing velocity especially
during the third trimester, when the
peak of growth has passed for skeletal
markers, AC variability is very large,
and birth is soon likely to occur.
Frequent ultrasound measurements are
also not presently recommended for
routine antenatal care and have impli-
cations for cost, staff numbers, and
workload. Our robust statistical
modeling work of the correlation of
fetal biometry measurements using a 2-
stage approach addressed at least some
of these limitations by enabling the
calculation of fetal biometry correla-
tions for any pair of observations be-
tween 14 and 40 weeks and is
independent of time interval.41
To facilitate the use of the standards
described here, we have provided an
easy-to-use R-shiny app (freely available
at https://lxiao5.shinyapps.io/fetal_
growth/) for assessing conditional ve-
locity if repeat ultrasoundmeasures are
clinically indicated. We believe that
both distance and velocity assessments
of fetal growth would help clinicians to
detect fetuses at risk of a growth ab-
normality. There are clinical advan-
tages of assessing growth using
conditional velocity. For instance, a
fetus may not meet its growth trajec-
tory, yet not fall below a cutoff centile
(such as the 10th); however, a size chart
would not identify that fetus as small
for gestational age, despite its evident
poor growth over time.
Research implications
This study’s findings offer new avenues
for both clinical and life sciences
research. It may now be possible to
identify more refined fetal growth phe-
notypes (or “fetotypes”), matching those
described for the neonate, which may be
associated with certain child health
outcomes. Hence, we encourage health
professionals worldwide to join us in
determining the clinical significance of
deviations from optimal skeletal and fat-
dependent growth by conducting
research to establish if routine fetal
growth velocity assessment can improve
health outcomes.70 External assessment
of the findings in daily practice,
including the implications of growth
above or below the standards, are areas
for future research. The potential path-
ophysiologic significance of the growth
velocity patterns identified here should
also prompt a renewed focus on research
into the underlying cellular and molec-
ular mechanisms responsible for fetal
growth.
Conclusions
We found that fetal growth velocity
increment is the highest in the early part
of the second trimester and decreases
with gestational age for skeletal struc-
tures and that there is a clear continuous
pattern throughout pregnancy for fat-
related markers such as AC. Further-
more, we constructed international Fetal
Growth Velocity Increment Standards
and conditional velocity to complement
the set of tools produced by the
INTERGROWTH-21st Project.12 A free,
simple-to-use, online clinical tool is
presented here, enabling the calculation
TABLE 6
Equations for the estimation of the expectedmean and SD velocity increment
(mm/wk) for each fetal biometry measurement according to gestational age
Fetal biometry Measurement Regression equation
HC Mean 10.43136þ1.377907((GA/10)2)
þ(1.431528((GA/10)2log(GA/10)))
SD 0.1791373þ(0.0425136(GA))
BPD Mean 2.263092þ0.6066072((GA/10)2)
þ(0.5224027((GA/10)2log(GA/10)))
SD 0.3886744þ(0.0022155(GA))
OFD Mean 4.308462þ0.2489315((GA/10)2)
þ(0.3629665((GA/10)2log(GA/10)))
SD 0.1167106þ(0.0273527(GA))
AC Mean 10.56711þ3.392895((GA/10)2)
þ(0.0285397((GA/10)3))
SD 1.137471þ(0.0349324(GA/10)3)
FL Mean 1.474157þ2.899183((GA/10)1)
þ(0.0147426((GA/10)3))
SD 0.2507282þ(0.0035916(GA/10)3)
All log are natural logarithms.
Centiles can be calculated as meanzSD, where z¼1.88, 1.645, 1.28, 0, 1.28, 1.645, and 1.88 for the 3rd, 5th,
10th, 50th, 90th, 95th, and 97th centiles, respectively, which are represented as C3, C5 C10, C50, C90, C95, and C97 in
Tables 1, 2, 3, 4, and 5.
AC, abdominal circumference, BPD, biparietal diameter; FL, femur length; GA, gestational age; HC, head circumference; OFD,
occipitofrontal diameter; SD, standard deviation.
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FIGURE 3
Screenshots of the fetal velocity app showing 4 example plots of longitudinal fetal growth evaluation based on
observed and predicted measurements for a fetus
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FIGURE 3
(Continued )
A, Normal fetus based on head circumference. B, Possible microcephaly based on head circumference. C, A fetus within 2 standard deviations. D,
Possible case of macrosomia based on abdominal circumference. All measurements were compared with the published international INTERGROWTH-
21st Fetal (Distance) Growth Standards.
INTERGROWTH-21st, International Fetal and Newborn Growth Consortium for the 21st Century.
Adapted from Papageorghiou et al.12
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of fetal growth velocity throughout
pregnancy. n
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SUPPLEMENTAL FIGURE 1
Increments in BPD and OFD (mm/wk) according to gestational age (weeks) for all of the sites combined
The fitted 3rd, 50th, and 97th centiles are superimposed.
Adapted from Papageorghiou et al.12
BPD, biparietal diameter; OFD, occipitofrontal diameter.
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SUPPLEMENTAL FIGURE 2
Median velocity increments in BPD (green) and OFD (red) according to
gestational age expressed as a percentage of the attained fetal size at 40
weeks’ gestation according to the published international INTERGROWTH-
21st Fetal (Distance) Growth Standards
BPD, biparietal diameter; INTERGROWTH-21st, International Fetal and Newborn Growth Consortium
for the 21st Century; OFD, occipitofrontal diameter.
Adapted from Papageorghiou et al.12
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SUPPLEMENTAL TABLE
Baseline characteristics of the FGLS
Characteristic
Pregnancies
(N¼4321)
Maternal age (y), mean (SD) 28.4 (3.9)
Maternal height (cm), mean (SD) 162.2 (5.8)
Maternal weight (kg), mean (SD) 61.3 (9.1)
Paternal height (cm), mean (SD) 174.4 (7.3)
Body mass index (kg/m2), mean (SD) 23.3 (3.0)
Gestational age at first visit (wk), mean (SD) 11.8 (1.4)
Years of formal education (y), mean (SD) 15.0 (2.8)
Hemoglobin level <15þ0 wk (g/dL), mean (SD) 12.5 (1.1)
Married or cohabiting, n (%) 4204 (97.3)
Nulliparous, n (%) 2955 (68.4)
Preeclampsia, n (%) 31 (0.7)
Pyelonephritis, n (%) 16 (0.4)
Any sexually transmitted infection, n (%) 3 (0.1)
Spontaneous initiation of labor, n (%) 2868 (66.4)
PPROM (<37þ0 wk), n (%) 80 (1.9)
Cesarean delivery, n (%) 1541 (35.7)
NICU admission >1 d, n (%) 240 (5.6)
Preterm (<37þ0 wk), n (%) 195 (4.5)
Preterm and spontaneous onset of labor, n (%) 126 (2.9)
Term LBW (<2500 g; 37þ0 wk), n (%) 128 (3.0)
Neonatal mortality, n (%) 7 (0.2)
Male sex, n (%) 2149 (49.7)
Exclusive breastfeeding at discharge, n (%) 3786 (87.6)
Mother admitted to intensive care unit, n (%) 17 (0.4)
Birthweight (kg) (37þ0 wk), mean (SD) 3.3 (0.4)
Birth length (cm) (37þ0 wk), mean (SD) 49.4 (1.9)
Birth head circumference (cm) (37þ0 wk), mean (SD) 33.9 (1.3)
FGLS, Fetal Growth Longitudinal Study; LBW, low birthweight; NICU, neonatal intensive care unit; PPROM, preterm prelabor rupture of membranes; SD, standard deviation.
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